Page | Chapter |
S79 | 1: Introduction (principles for developing the guidelines) |
S81 | 2: Key flowchart for initial treatment of community-acquired pneumonia in adults |
S82 | 3: Definition of pneumonia |
S83 | 4: Diagnosis of community-acquired pneumonia |
S84 | 5: Severity classification of pneumonia |
S86 | 6: Judgment on whether an outpatient or inpatient setting is appropriate for treatment |
S88 | 7: Aetiological agents of community-acquired pneumonia and test methods |
S92 | 8: Differentiating between bacterial pneumonia and atypical pneumonia |
S94 | 9: Viral pneumonia |
S98 | 10: Point of view on Legionella pneumonia |
S99 | 11: New point of view on the use of antimicrobial agents |
S101 | 12: Empiric treatment of community-acquired pneumonia in adults |
S102 | 13: Selection of antimicrobial agents when the aetiologic agent has been identified |
S104 | 14: Indications for whether oral or injection drugs should be used |
S105 | 15: Cautions when antimicrobial therapy is administered to elderly patient |
S107 | 16: How to use corticosteroids or immunoglobulin |
S109 | 17: General treatment of pneumonia |
S111 | 18: Indications for timing of treatment initiation, assessment of response to treatment, timing of treatment completion, and timing of hospital discharge |
S113 | 19: Treatment of pneumonia unresponsive to antimicrobial agents |
S115 | 20: Prevention of community-acquired pneumonia |
S117 | 21: Diagnosis, treatment, and prevention of aspiration pneumonia (excluding large-volume aspiration) |
S119 | 22: List of antimicrobial agents to treat respiratory infections |